4/20 ACE Group Joins National Taiwan Ocean University for Beach Cleanup, Creating a Beautiful Coastline

Caption: ACE Group (ACE Solution, ACE Biotek) Beach Cleanup Activity

(Hsinchu, Taiwan – April 20, 2024) – ACE Group held its annual beach cleanup event on April 20 at the HSIN FENG Beach in Hsinchu. The event was attended by employees, their families, and students from National Taiwan Ocean University, all coming together to protect the marine environment through practical action.

ACE Group has been committed to environmental protection for many years. Since 2010, they have adopted the HSIN FENG Beach in Hsinchu and have organized regular cleanup activities every year, calling on employees and their families to join in protecting the coastline. In commemoration of its 20th anniversary, ACE Group expanded its efforts by collaborating with National Taiwan Ocean University to conduct the beach cleanup, combining professional knowledge and action to contribute to marine conservation.

On the day of the event, participants, including colleagues and family members, worked hard to pick up litter, including plastic bottles, bags, Styrofoam, and cigarette butts. After two hours of effort, they cleared dozens of trash bags, significantly contributing to cleaning up the marine environment.

ACE Group has always placed great importance on environmental protection. Marine debris affects marine life and poses health risks to humans. Through beach cleanup activities, ACE Group hopes to raise awareness of the importance of the marine environment, share knowledge and ideas about marine conservation with more people, and work together to protect marine ecology. In the future, ACE Group will continue to promote environmental protection activities and collaborate with various sectors to create a sustainable home.

2/20 ACE Biotek Invited by Government Agency to Host US Medical Industry Visit, Featuring Exchange Event with Renowned Biomedical Scholars

Caption: From left to right: Huang Yuxing, Hsinchu Science Park Bureau of National Science and Technology Council, Lilibeth Martinez, Director Nicholas Hu, ACE Biotek President Steve Hsu, ACE Biotek RD Vice President Dr. JC Chen, Dr. Jason Liauw, ACE Biotek RD Manager Dr. Harry Kuan

Hsinchu, Taiwan – February 20, 2024 – ACE Biotek has been invited by the Hsinchu Science Park Bureau to be one of the essential venues for visiting the US biomedical field. Three distinguished scholars, including Dr. Jason Liauw, spine and neurosurgery authority from Stanford University Medical Center, biomedical engineer Lilibeth Martinez from Brown University, and Nicholas Hu, Chairman and General Manager of TEPKOS, visited for the event.

ACE Biotek’s journey from 3C to medical care extends from its 20-year experience in strong wireless communication, 5G, IoT, and other hardware and software integration testing to smart medical care and biomedical testing. The three guests were deeply impressed by the cultural impact of ACE Biotek’s art gallery. They visited the special exhibition of inorganic materials and calligraphy at the Industrial Technology Research Institute, experiencing Chinese art through calligraphy, integrating art and imagination into the work of technologists.

Dr. JC Chen, Vice President of Research and Development at ACE Biotek, shared the application of Terahertz technology. Terahertz technology, or submillimeter wave, is between 5G millimeter wave and infrared, with a wavelength of 0.03-3mm. It can efficiently penetrate and see through objects, with the characteristics of non-contact and non-destructive, and is widely used in pill and cell imaging detection.

ACE Biotek has signed MOUs with dozens of partners. This visit will help to consolidate cross-border cooperation between Taiwan and the United States in the biomedical industry and among researchers.

12/7 Digital Hospital Development and Milestone in AI Clinical Applications-ACE Biotek Signs Memorandum of Understanding with Taichung Armed Forces General Hospital

Caption: Chen Ying-Kai, Director of Taichung Armed Forces General Hospital (Left), Steve Hsu, Chairman of ACE Biotek (Right)
Caption: Chen Ying-Kai, Director of Taichung Armed Forces General Hospital (Left), Steve Hsu, President of ACE Biotek (Right)
Caption: Director Chen Ying-Kai (7th from the left) and Vice Director Jane-Dar Lee (6th from the left) of Taichung Armed Forces General Hospital, along with President Steve Hsu (5th from the right) of ACE Biotek.

To promote collaboration in the integration of smart healthcare information systems, AI technology, and clinical applications, ACE Biotek and Taichung Armed Forces General Hospital signed a MOU on December 7, 2023, followed by an on-site visit. The event was led by Director Chen Ying-Kai, with Vice Director Jane-Dar Lee and other chief physicians present for the exchange.

The collaboration between the two parties originated from an earlier healthcare system alliance event this year—the alliance aimed to facilitate cooperation between industry, academia, research, and the medical field. Following a visit and experiential activities led by the Department of Internal Medicine and the Research Department of Taichung Armed Forces General Hospital, both parties engaged in in-depth discussions on smart healthcare. Subsequently, they formalized their collaboration by signing the MOU and outlining plans for future cooperation.

As part of the MOU and visit, ACE Biotek arranged a special presentation showcasing smart healthcare products, including the UniiForm Digital Handwriting System, InfinityAI & Einthoven ECG patch, applications of smart upload systems (ophthalmology, anesthesia, physiological monitors), sharing on trauma care and military medical practices, and Terahertz (THz) detection technology.

Director Chen Ying-Kai of Taichung Armed Forces General Hospital emphasized, “At the current stage, our hospital envisions achieving the level of a medical center and is dedicated to developing distinctive medical services, implementing holistic care, and initiating smart healthcare for precise quality care. The hospital is currently constructing a new medical building, scheduled to be completed in the year of 2025, to safeguard the health of the military and civilians in central Taiwan. ACE Biotek has demonstrated outstanding effectiveness in AI smart healthcare integration solutions. Through this collaboration, we hope to leverage the clinical expertise of our hospital and the research and development capabilities of ACE Biotek to jointly build a smart hospital and personalized healthcare, striving to enhance patient safety and the efficiency of healthcare professionals.”

President Steve Hsu of ACE Biotek stated, “ACE Biotek has accumulated successful healthcare system development and integration cases in over 50 hospitals in Taiwan. We focus on structuring medical data and electronic medical records for various specialties, achieving efficiency gains in the workforce, and improving the utilization of medical data. Taichung Armed Forces General Hospital has excellent healthcare professionals and is crucial in providing enhanced medical services to soldiers and their families in the central region. ACE Biotek anticipates creating multiple benefits for the smart healthcare industry through collaboration, leveraging our elite software and hardware engineering teams, and the expertise of healthcare professionals and knowledge in the medical field at Taichung Armed Forces General Hospital.”

Taichung Armed Forces General Hospital, the central military medical center in the central region, has been recognized through the regional teaching hospital evaluation by the Ministry of Health and Welfare. It boasts outstanding specialist physicians, advanced and comprehensive medical equipment, a digital medical environment, continuous improvement in teaching and research, and enhanced patient services. ACE Biotek, transitioning from 3C to medical industry, combines its experience in wireless communication hardware and software integration with AI platform technology to develop smart healthcare upload solutions. The signing of this MOU marks a milestone in the development of “Smart Healthcare Information System Solutions and AI Software Applications.”

11/1 ACE Biotek Partners with TWCA to Propel a New Era of Digital Medical Signatures and Information Security

Caption: ACE Biotek Chairman’s Assistant and Chief Information Security Officer, Mr. KC Chen

Hsinchu, Taiwan – November 1, 2023 – ACE Biotek and TAIWAN-CA (TWCA) proudly announce the signing of a MOU to address the critical concerns of information security in the healthcare sector. The development of smart hospitals often needs to improve information security and the establishment of legally binding document signatures. To meet these challenges, ACE Biotek has collaborated with TWCA to seamlessly integrate TWCA’s electronic signature and digital certificate technology into the existing ACE Biotek Uniiform digital handwriting system. This integration aims to provide a comprehensive solution that records digital signature trails and facilitates digital document storage.

As a pioneer of intelligent solutions in the healthcare industry, ACE Biotek has successfully led numerous departments toward digital transformation. Through products like Uniiform and DS, ACE Biotek has digitized handwritten medical records and enabled the capture and analysis of instrument data. TWCA, a globally recognized network authentication service provider, excels in information security and offers solutions such as digital signatures, certificates, and identity verification. Mr. KC Chen, Chairman’s Assistant, and Chief Information Security Officer of ACE Biotek, expressed his enthusiasm for this interdisciplinary collaboration, stating, “This partnership enhances the security and convenience of handwritten electronic forms and signatures in hospitals. Leveraging our strong backgrounds in information security and the medical field, ACE Biotek and TWCA have embarked on this cross-disciplinary endeavor.”

The collaboration between the two companies harnesses their respective strengths and aims to streamline the workflow of hospital IT departments. Moreover, it establishes mechanisms for legally binding documents. The primary focus of this cooperation is on Uniiform’s electronic signature solution and DS device identity verification. Uniiform, a core product of ACE Biotek, enables real-time digitalization of handwritten documents while retaining users’ handwriting habits and providing history records. By integrating TWCA’s information security solutions, the Uniiform electronic signature solution ensures practical legal effectiveness and traceable signature records, satisfying both online digital application and offline signing needs. The DS device identity verification solution aims to guarantee the identity of all hospital devices, enabling quick traceability of device operation history to enhance information security within the healthcare facility.

With the increasing focus on healthcare information security, the demand for legally effective electronic signatures continues to grow. The partnership between ACE Biotek and TWCA will pioneer new trends in healthcare information security. It will provide scientific and reliable solutions for hospitals to implement digital applications and signing mechanisms, ensuring the security of patient data and information. The future outlook includes expanding market applications to meet the needs of hospitals and government agencies. This collaboration is expected to drive Taiwan’s healthcare industry toward secure digital transformation and serve as a reference point for the global medical sector.

About ACE Biotek

Established in 2000, ACE Group has grown over 20 years across wireless and healthcare industries. ACE Biotek, founded in 2018 by President Steve Hsu, integrates 20 years of industrial experience and knowledge to solve unmet clinical needs. ACE Biotek develops smart medical solutions encompassing imaging algorithms, cloud computing, artificial intelligence, and terahertz technology, with a focus on achieving early disease diagnosis. In the long term, ACE Biotek aims to expand globally, serving as a platform to foster talent and support tech companies in their transformation into Medtech.

Contact ACE Biotek

Advanced ACE Biotek Co., Ltd.

Address: Hsinchu Biomedical Science Park, No. 66, Shengyi 2nd Rd., Zhubei City, Hsinchu County 302, Taiwan

Phone: +886-3-5500909

E-mail: service@acebiotek.com

Website: https://www.acebiotek.com/

Facebook: https://www.facebook.com/Acebiotek/

LinkedIn: https://www.linkedin.com/company/30620922/admin/

ACE Biotek Joins the 2023 Kiss Science Event by the National Science and Technology Council

Figure1: ACE Biotek Kiss Science (National Hsinchu Industrial High School)
Figure2: ACE Biotek Kiss Science (Chiayi County Yung Ching Senior High School)

To inspire young minds to explore scientific research, the National Science and Technology Council has consistently hosted the “2023 Kiss Science – Unveiling Science, No More Dull Youth” event for the last five years. Commencing on October 14, 2023, and spanning five consecutive weekends, this initiative has opened doors to 106 venues across Taiwan, hosting more than 370 events. ACE Biotek, a pioneering name in Taiwan’s digital healthcare solution, has been invited to showcase its expertise by opening its corporate premises to students. On October 17, 2023, the company welcomed students from Hsinchu Industrial High School and Chiayi County Yung Ching Senior High School, offering them the opportunity to experience, interact, and engage in discussions to broaden their horizons and enhance their competitiveness.

ACE Biotek has made significant strides in promoting its electronic medical record and smart data integration solutions in various medical fields, including anesthesiology and ophthalmology. It has revolutionized the transition to electronic health records without altering healthcare professionals’ handwriting habits. The company extracts instrument data and processes it into a structured format. Early disease screening holds immense importance, necessitating state-of-the-art equipment for high-precision diagnosis. ACE Biotek combines multiple technological elements, including semiconductor chips, medical imaging algorithms, cloud technology, and artificial intelligence. Incorporating clinical expertise, regulatory certifications, and patented technology has led to the developing of advanced early disease screening systems.

The event commenced with guided tours through ACE Art Gallery, offering students insight into the fusion of technology and humanity within the corporate culture. Furthermore, students were given the opportunity to tour ACE Group’s transformation journey, transitioning from the 3C to Medical: Medical Talent, Medical Technology, and Medical Device. ACE Biotek also shared and delved into nurturing local medical talent and contributing to developing biotechnology, medicine testing, and medical equipment. The company presented a range of innovations, including the Uniiform Digital Handwriting System, AI integration into post-pandemic standard equipment, such as the O-Ring automatic hand dispenser, Wallie Screen thermal scanner, Einthoven ECG (Electrocardiogram) patches for remote healthcare, and THz (Terahertz) technology suitable for tablet or pathology slide applications. All these innovations were demonstrated through interactive experiences, informative lectures, and video presentations.

ACE Biotek has consistently emphasized talent development, believing in the correlation between the team’s growth and the company’s success. As a result, the company has been relentlessly working to provide the best nurturing and development environment, ensuring that every employee can fully realize their potential. The mission of ACE Biotek, evolving from 3C to Medical, underscores the company’s commitment to nurturing talents. Furthermore, ACE Biotek has extended its talent education into Corporate Social Responsibility (CSR), encouraging employees to participate in community service and charitable activities actively. This integration between personal growth and societal contribution is aimed at fostering a broader perspective within the team. From October 4 to December 29, 2023, the ACE Art Gallery will feature “Passing on Love DNA,” inviting the Evergreen Choir and Green Light Seed Classroom to convey love through songs and culture. All are welcome to attend.

About ACE Biotek

Established in 2000, ACE Group has grown for more than 20 years across wireless and healthcare industries. Originally, ACE Group formed ACE Solution as its first foray to focus on wireless communication, networking hardware, and customized system integration projects. Driven by President Steve’s vision to improve healthcare quality, he built the ACE Biotek building from the ground up and officially founded ACE Biotek in 2018. ACE Biotek integrates the past 20 years of industrial experience and knowledge to solve unmet clinical needs. In order to achieve the early diagnosis of diseases, we have developed smart medical solutions regarding imaging algorithms, cloud computing, artificial intelligence, and terahertz technology so far. Long term, ACE Biotek will expand globally to serve as a platform to cultivate talents and support tech companies to transform into Medtech.

Contact us

Advanced ACE Biotek Co., Ltd.

Address: No. 66, Shengyi 2nd Rd., Zhubei City, Hsinchu County 302, Taiwan (Hsinchu Biomedical Science Park)

Phone: +886-3-5500909

E-mail: service@acebiotek.com

Website: https://www.acebiotek.com/

Facebook: https://www.facebook.com/Acebiotek/

LinkedIn: https://www.linkedin.com/company/30620922/admin/

6/29 ACE Biotek and Proscend Successfully Hold 5G x Smart Health Cross-Border Seminar Showcasing Innovative IoT Applications and New Opportunities in Smart Healthcare Services

Caption: KC Chen, VP of ACE; Jason Lin, Director of TRANSNET; Alpha Chen, GM of PROSCEND; Jim Chen, Chairman of PROSCEND; Steve Hsu, President of ACE; Chanson Lin, President of EmBestor Technology; Kevin Kuo, ASD Supervisor of ACE; Eden Chao, Sr. Technical Manager of ACE; Nick Chiang, Hospital IT Professionals of ACE

ACE Biotek and Proscend successfully held the remarkable 5G x Smart Health Cross-Border Seminar on June 29, 2023, showcasing innovative IoT applications and new opportunities in smart healthcare services—the seminar aimed to demonstrate the outstanding collaborative achievements of the two companies. ACE Solution brings rich experience in wireless communication testing, AI technology, and medical data transmission, while Proscend excels in 5G, AIoT connectivity, smart internet services, and the development of high-value solutions, creating exemplary success stories for diverse vertical industries. The collaboration between the two companies has resulted in the development of comprehensive solutions that meet market demands.

The esteemed speakers for this event included Jason Lin, Director of TRANSNET, who delivered a fascinating analysis of empowering the intelligent 5G private network and creating a new digital transformation era by exploring key policies and international development trends and providing examples of their applications. Alpha Chen, GM of Proscend, shared insights into the industrial IoT smart applications of 5G x Edge AI computing, aiming to bring more innovative and high-quality service applications to meet the needs of smart healthcare. By forging alliances and co-creating an ecosystem of shared value, the goal is to advance together into new blue oceans, generate shared opportunities, and drive industry economic benefits. KC Chen, VP of ACE Biotek; Chanson Lin, President of EmBestor Technology; Nick Chiang, Hospital IT Professionals of ACE Biotek; Eden Chao, Sr. Technical Manager of ACE Solution; and Kevin Kuo, ASD Supervisor of ACE Biotek, discussed topics such as information security, hospital information system applications, 5G NR, WiFi 7, NB-IoT, and related issues.

The seminar also featured a showcase of several astonishing technological achievements, including 5G x Edge AI Intelligent Edge Computing Integration Solution, Smart Air Quality Management for Medical Facilities, O’smart IoT Smart Agile Management Service Platform, Intelligent Long-Distance Digital Network Communication Integration Solution, UniiForm Smart Handwriting Assistance System – Hand-drawn Electronic Medical Record Application, 5G testing solutions, Spark Smart Anesthesia Recording System, and DS Smart Upload Integration Solution. These demonstrations highlighted the strengths of both parties’ technologies and the innovative services with broad future applications.

This collaboration and seminar effectively leveraged the synergistic effects of both parties’ technologies to introduce more intelligent and advanced technological applications to the healthcare industry. ACE Biotek and Proscend will continue to deepen their cooperation, striving to promote the application of 5G and AIoT in smart healthcare, bringing more innovation and breakthroughs and further enhancing smart healthcare services.

About Proscend

Founded in 1999, Proscend is a leading provider of industrial IoT connectivity solutions, empowering the future of 5G and AIoT innovation. With a commitment to excellence and continuous improvement, Proscend stands at the forefront of creating unique and differentiated solutions, guiding us towards an infinite future. With an agile and customer-centric approach, Proscend serves over 60 countries globally as a trusted partner, delivering high-quality industrial-grade networking equipment and optimized IoT management platforms. By offering top-notch and robust solutions, Proscend enables efficient and intelligent transformations across multiple industries, including smart cities, smart transportation, smart energy, smart retail, and smart healthcare. Proscend is dedicated to fostering a symbiotic, prosperous, and sustainable world.

Contact Proscend

Proscend Communications Inc.

Address: 2F, No. 36, Industrial East 4th Rd., Hsinchu Science Park, Hsinchu City 300093, Taiwan

Phone: +886-3-5639000

E-mail: sales@proscend.com

Website: https://www.proscend.com/

About ACE Biotek

Established in 2000, ACE Group has grown over 20 years across wireless and healthcare industries. ACE Biotek, founded in 2018 by President Steve Hsu, integrates 20 years of industrial experience and knowledge to solve unmet clinical needs. ACE Biotek develops smart medical solutions encompassing imaging algorithms, cloud computing, artificial intelligence, and terahertz technology, with a focus on achieving early disease diagnosis. In the long term, ACE Biotek aims to expand globally, serving as a platform to foster talent and support tech companies in their transformation into Medtech.

Contact ACE Biotek

Advanced ACE Biotek Co., Ltd.

Address: Hsinchu Biomedical Science Park, No. 66, Shengyi 2nd Rd., Zhubei City, Hsinchu County 302, Taiwan

Phone: +886-3-5500909

E-mail: service@acebiotek.com

Website: https://www.acebiotek.com/

Facebook: https://www.facebook.com/Acebiotek/

LinkedIn: https://www.linkedin.com/company/30620922/admin/

6/12 ACE Biotek and Proscend Sign Memorandum of Understanding – Collaborating to Create a New Era of 5G Smart Healthcare

Caption: Jim Chen, Chairman of Proscend; Steve Hsu, Chairman of ACE Biotek; Alpha Chen, General Manager of Proscend

Hsinchu, Taiwan – ACE Biotek and Proscend officially signed an MOU on June 12, 2023. Mr. Steve Hsu, Chairman of ACE Biotek, and Mr. Jim Chen, Chairman of Proscend, attended the signing ceremony. The collaboration aims to strengthen cooperation in 5G private networks, AIoT, AI, and DS gateways for smart internet and smart hospitals, to create mutual value.

Both companies will collaborate on integrating solutions for the application of 5G and AIoT in smart IoT and smart hospital environments. Proscend brings its expertise to 5G and Edge AI technologies, while ACE Biotek contributes its knowledge in AI, Uniiform, DS gateways, and other hardware and software applications. The companies will jointly develop comprehensive solutions that meet market demands through this partnership. ACE Biotek is committed to developing smart healthcare solutions encompassing wireless communication testing, AI technology, and medical data transmission. Proscend focuses on the research and design of 5G and AIoT vertical applications and smart internet services. This collaboration presents new opportunities for the advancement of 5G smart healthcare.

Mr. Steve Hsu, Chairman of ACE Biotek, expressed his enthusiasm, stating, “Emerging technologies such as 5G and AIoT have immense potential in the field of smart healthcare. We look forward to collaborating with Proscend to develop innovative solutions that facilitate telemedicine and integrate medical data, ultimately providing healthcare professionals greater convenience and delivering increased value to the healthcare industry.” Mr. Jim Chen, Chairman of Proscend, added, “We have established ourselves as pioneers in the digital application of 5G and AIoT in Taiwan and have expanded our reach to encompass diverse business opportunities. This partnership will leverage the strengths of both companies, driving the development of 5G smart healthcare and introducing intelligent and advanced technological applications to the medical industry.”

To further promote the achievements of this collaboration, ACE Biotek and Proscend will host the “5G x Smart Healthcare Cross-Border Seminar” on June 29th. The seminar will feature presentations by industry leaders and professionals in Proscend, ACE Biotek, Transnet, Embestor, and hospital information systems/platforms. Attendees will gain in-depth insights into the latest trends and applications of 5G, AIoT, and smart healthcare. Advanced registration is now open at the following website:

Online Registration: https://register.acesolution.com.tw/20230629_5GxSmartHealth_Seminar

About Proscend

Founded in 1999, Proscend is a leading provider of industrial IoT connectivity solutions, empowering the future of 5G and AIoT innovation. With a commitment to excellence and continuous improvement, Proscend stands at the forefront of creating unique and differentiated solutions, guiding us towards an infinite future. With an agile and customer-centric approach, Proscend serves over 60 countries globally as a trusted partner, delivering high-quality industrial-grade networking equipment and optimized IoT management platforms. By offering top-notch and robust solutions, Proscend enables efficient and intelligent transformations across multiple industries, including smart cities, smart transportation, smart energy, smart retail, and smart healthcare. Proscend is dedicated to fostering a symbiotic, prosperous, and sustainable world.

Contact Proscend

Proscend Communications Inc.

Address: 2F, No. 36, Industrial East 4th Rd., Hsinchu Science Park, Hsinchu City 300093, Taiwan

Phone: +886-3-5639000

E-mail: sales@proscend.com

Website: https://www.proscend.com/

About ACE Biotek

Established in 2000, ACE Group has grown over 20 years across wireless and healthcare industries. ACE Biotek, founded in 2018 by President Steve Hsu, integrates 20 years of industrial experience and knowledge to solve unmet clinical needs. ACE Biotek develops smart medical solutions encompassing imaging algorithms, cloud computing, artificial intelligence, and terahertz technology, focusing on achieving early disease diagnosis. In the long term, ACE Biotek aims to expand globally as a platform to foster talent and support tech companies in transforming into Medtech.

Contact ACE Biotek

Advanced ACE Biotek Co., Ltd.

Address: Hsinchu Biomedical Science Park, No. 66, Shengyi 2nd Rd., Zhubei City, Hsinchu County 302, Taiwan

Phone: +886-3-5500909

E-mail: service@acebiotek.com

Website: https://www.acebiotek.com/

Facebook: https://www.facebook.com/Acebiotek/

LinkedIn: https://www.linkedin.com/company/30620922/admin/

6/9 Indonesia’s PT Norma and Taiwan’s ACE Biotek Collaborate to Develop Indonesian Hospital Market

Caption: Eva Hayati, Operational Director of PT Norma and Steve Hsu, President of ACE Biotek
From left to right: Arrahman Oktavianda, Engineer Manager of PT Norma, Rudi Antoni, President Director of RAFA Topaz Utama, Steve Hsu, President of ACE Biotek, and Eva Hayati, Operational Director of PT Norma

[Taipei, Taiwan / Jakarta, Indonesia – June 9, 2023] Advanced ACEBIOTEK CO., LTD. (ACE Biotek) and PT NORMA Diagnostika Indonesia (PT Norma) are delighted to announce the signing of a Memorandum of Understanding (MOU) on June 9, 2023. This collaboration aims to jointly develop and explore opportunities in the Indonesian hospital market. Representatives in the signing ceremony are Steve Hsu, President of ACE Biotek, and Eva Hayati, Operational Director of PT Norma. Notably, the contract signing uses the Uniiform smart pen, symbolizing the integration of innovative technology into the partnership.

PT Norma, a leading provider of information systems (HIS) for Indonesian hospitals, is partnering with ACE Biotek, a specialist in developing smart hospital technologies. The collaboration will focus on integrating ACE Biotek’s Uniiform Smart Handwriting System (UniiForm) software into PT Norma’s HIS system. This integration will enable the introduction of advanced healthcare solutions in Indonesian hospitals, streamlining medical staff efforts and enhancing the quality of care. Uniiform preserves user behavior and synchronously uploads handwriting records in real-time, facilitating a paperless environment and enabling AI-driven extensive data analysis and early disease diagnosis.

The partnership between ACE Biotek and PT Norma originated from a visit where PT Norma witnessed ACE Biotek’s technological achievements. Recognizing the market potential and aligning with the Southeast Asian EMR trend, PT Norma identified Uniiform as the cutting-edge product that complements its vision for the Indonesian healthcare sector. This MOU signifies a significant stride towards advancing healthcare technology in Indonesia. By combining expertise, the companies aim to contribute to meet patient care enhancement and smart hospital development.

Expressing his enthusiasm for the partnership, Mr. Steve Hsu, President of ACE Biotek, stated, “We are excited to collaborate with PT Norma to introduce our Uniiform Smart Handwriting System to Indonesian hospitals. The MOU represents a significant step towards enhancing healthcare technology in Indonesia and improving patient care.”

Ms. Eva Hayati, Operational Director of PT Norma, shared similar sentiments, remarking, “We believe that the Uniiform Smart Handwriting System has immense potential in the Indonesian market. By integrating Uniiform into our HIS system, we aim to offer an advanced system that aligns with the EMR trends. We will expand the user reference site to multiple hospitals across Indonesia.”

For media inquiries, please contact:

Advanced ACE Biotek Co., Ltd.:

Jenny Lin

Address: No. 66, Shengyi 2nd Rd., Zhubei City, Hsinchu County 302, Taiwan (Hsinchu Biomedical Science Park)

Phone: +886-3-5500909#3407

E-mail: jenny_lin@acebiotek.com

Website: https://www.acebiotek.com/

Facebook: https://www.facebook.com/Acebiotek/

LinkedIn: https://www.linkedin.com/company/30620922/admin/

PT NORMA Diagnostika Indonesia:

Arrahman Oktavianda

Address: Jl. KRT Radjiman Widyodiningrat No A23 Cakung, Jakarta Timur, 13930

Phone: +6282317171799

E-mail: oktavianda@normaindonesia.co.id

Website: https://www.normaindonesia.co.id/

About ACE Biotek

Established in 2000, ACE Group has grown for more than 20 years across wireless and healthcare industries. Originally, ACE Group formed ACE Solution as its first foray to focus on wireless communication, networking hardware, and customized system integration projects. Driven by President Steve’s vision to improve healthcare quality, he built the ACE Biotek building from the ground up and officially founded ACE Biotek in 2018. ACE Biotek integrates the past 20 years of industrial experience and knowledge to solve unmet clinical needs. In order to achieve the early diagnosis of diseases, we have developed smart medical solutions regarding imaging algorithms, cloud computing, artificial intelligence, and terahertz technology so far. Long term, ACE Biotek will expand globally to serve as a platform to cultivate talents and support tech companies to transform into Medtech.

About PT Norma

Established in 2014, PT. Norma has grown for almost than 10 years in the In Vitro Diagnostics and IT Healthcare Solution business across Indonesia. From its first foundation, PT. Norma Diagnostika Indonesia is focused on distribution of In Vitro Diagnostics medical devices and its consumables as well. In 2017, PT. Norma Diagnostika Indonesia start cooperation with Hospital Information System provider based in South Korea, and nowadays PT. Norma focusing on distributing IT Healthcare Solution with additional cooperation with PACS from South Korea and Laboratory Information Management System from India. In long term, PT. Norma will expand its business to become One-stop Solution for IT Healthcare in Indonesia.

5/30 ACE Biotek and TWCA (TAIWAN-CA Inc.) Sign Memorandum of Understanding to expand collaboration on Uniipen Smart Pen Technology and Electronic Signature Applications

Caption: Steve Hsu, President of ACE Biotek (left), and Stephen Lee, Chairman of TWCA (right), representing the signing of the ceremony.

ACE Biotek, known for its successful implementation of smart hospital solutions, officially signed a cooperation memorandum with TWCA on May 30, 2023. The collaboration aims to enhance the partnership between Uniipen smart pen technology and electronic signature applications, working together to create mutual value. Stephen Lee, Chairman of TWCA, and Steve Hsu, President of ACE Biotek, represented the signing ceremony.

TWCA is a leading global provider of network certification services dedicated to driving digital transformation and providing secure and reliable authentication solutions. Its innovative technology and excellent service quality have earned complete customer trust. As the pioneer from 3C to the medical industry, ACE Biotek combines its expertise in wireless communication hardware and software integration with AI platform technology to develop smart medical data upload solutions. These solutions are applied to electronic medical record digitization and instrument data acquisition and analysis, with successful collaborations and implementations in representative domestic hospitals. The signing of this MOU aims to combine the technical strengths of both parties by integrating electronic signature or encryption technology into smart handwriting applications.

Steve Hsu, President of ACE Biotek, stated that the signing of this cooperation memorandum represents an innovative strategy. In addition to being used for EMR, Uniiform smart handwriting system is also utilized with the Data Stream Gateway (DS), which retrieves and integrates device data. By combining it with TWCA’s electronic signature technology in the future, the applications can be expanded from healthcare to other industries. Integration with companies in the science park makes it possible to introduce the technology into more underserved areas.

Stephen Lee, Chairman of TWCA, also emphasized that this collaboration will focus on the innovative integration of electronic signatures with Uniipen smart pens. It represents the perfect combination of both companies’ core competencies and business focus. Through cooperation with ACE Biotek, the goal is to provide customers with a superior, convenient, and secure experience in handwritten electronic forms. The success of this collaboration is expected to bring continued growth and mutual value to both parties.

5/17 Collaboration Insights of TZ6000 from TeraView– The Nondestructive Wafer Testing Accomplishment in Semiconductor Industry

From left to right: TZ6000 System with TeraPulse Lx; Dr. Don Arnone, CEO of TeraView and Steve Hsu, President of ACE Solution

Dr. Don Arnone is the CEO of TeraView. In March 2023, he visited ACE Solution (ACE), the Taiwan representative partner that launched the TZ6000, a non-destructive wafer quality measurement tool. It incorporates with TeraView’s TeraPulse Lx technologies, particularly for crucial applications such as wafer and substrate defect inspection. TZ6000 characterizes the wafer properties by thickness, refractive index, resistivity, dielectric constant, and surface/subsurface defects scanning graph.

Key Driving Factors for TZ6000 Success and Market Advantages

To explore the market for TZ6000, Dr. Don Arnone shares two influencing factors: ” One is to transmit product information; the other is to make a demonstration to customer in terms of favorable impression.” Since 2023, the proof of concept (POC), the initial sales, will rely on sturdy teamwork. Based on ACE and TeraView professionals, TZ6000 is the thriving base for forward-looking. TeraView possesses competitive advantages of Terahertz instrument experience, while ACE has tremendous expertise for integration solutions such as TZ6000. Under the two leading companies’ cross-border cooperation, it will bring an unprecedented solution for customers.

Subsurface Damage (SSD) of semiconductor wafers commonly happens in the surface machining process. At present, wafer inspection relies on VIS/IR/UV optical inspection that can analyze the surface properties of the wafer but not the SSD because of its low penetration depth. Terahertz (THz) waves have the features of high penetration depth in semiconductor wafers for silicon, silicon carbide, and gallium nitride. Therefore, THz-based TZ6000 can meet the market needs for compound semiconductor wafer non-destructive inspection.

TZ6000 Accomplishment Insights from ACE and TeraView

From Dr. Don Arnone’s viewpoint, there are three takeaways for TZ6000 task achievement. ACE works enthusiastically and hard to reach our milestones and follows customer requirements. In addition, team flexibility brings the capability to address the challenge of market adoption. These factors are also key to take the TZ6000 from the project phase through to final commercialization. TeraView’s TeraPulse Lx System is the pioneer product for terahertz analysis. Specifically, it meets material inspection in imaging or spectroscopy applications for the compound semiconductor industry. The modular architecture and patented laser-gated photoconductive emitters and detectors are flexible and expandable. The system also boasts an industry-leading 3,200 ps time-delay line as standard. With a lightweight, compact core unit that allows easy transport, the TeraPulse Lx System incorporates the TeraPulse Lx modules to meet market demands.

Steve Hsu, President of ACE, says it’s a precious chance to collaborate with TeraView. ACE takes the lead in electrical precision tests, integrating service and solution. Through the TeraPulase Lx module and TZ6000 system incorporation, it frames a unique THz-TDS probe for simultaneous measurement of multiple parameters of wafer characterization. In the wafer manufacturing and R&D process, TZ6000 possesses user-friendly and graphically illustrated software for quality inspection. “TeraView and ACE have very complimentary skills and experience. Our partnership is a representative case of international cooperation. I’m proud of this unique accomplishment and enjoying working with President Steve’s team.”, Dr. Don Arnone says with trust. Starting the TZ6000 business in Taiwan, ACE has confidence in creating a great business via technology integration in the long run.